KRAS and colonic neoplasm: Due to the extensive cytotoxicity induced by GANT61 in human models of colon cancer [36, 38, 39], data suggest that GLI is a critical target in colon cancer cell survival, and also in other cancers where GLI is constitutively activated and/or an oncogenic KRAS-GLI axis drives proliferation.